ReviewJournal of hematology & oncology2016

Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer.

Shuhang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.